Analysis of TCGA data has shown that CNPY2 expression is significantly increased in both adenocarcinoma and squamous cell carcinoma, which together account for approximately 85% of NSCLC cases [12]. The gene discussed is CNPY2; the disease is non-small cell lung carcinoma.